Idacta-mab INT-001 represents a promising clinical approach for combating certain blood-related cancers. This particular antibody shows an unique mechanism of effect, particularly targeting the CD38 antigen, a cell-surface molecule present widely on multiple hematopoietic populations. Ongoing patient trials aiming to evaluate the security and ef… Read More

Recombinant mouse granulocyte colony-stimulating protein, often abbreviated as G-CSF, represents a valuable therapeutic agent in modern healthcare. Produced via advanced biotechnological methods, this protein is essentially a isolated version of a endogenously occurring growth factor that encourages the production of white blood cells. Its thera… Read More